73 Views | 34 Downloads
Erin D. Michos, MD, MHS, FACC, FAHA, Associate Professor of Medicine, Ciccarone Center for the Prevention of Cardiovascular Disease, Division of Cardiology, Department of Medicine, Johns Hopkins University School of Medicine, Blalock 524-B, 600 N. Wolfe Street, Baltimore, MD 21287, USA. E-mail: edonnell@jhmi.edu
The authors thank the other investigators, the staff, and the participants of the ARIC study for their important contributions. A full list of participating ARIC investigators and institutions can be found at https://www2.cscc.unc.edu/aric/.
Dr. Hoogeveen has received grant support and consulting fees from Denka Seiken outside the submitted work. Dr. Ballantyne: grants/research support (paid to institution, not individual) and consultant: Abbott Diagnostic, Denka Seiken, Roche Diagnostic. Drs. Hoogeveen and Ballantyne are coinventors on a provisional patent (patent #61721475) entitled Biomarkers to Improve Prediction of Heart Failure Risk filed by Roche and Baylor College of Medicine on their behalf.
This work was funded by the American Heart Association Go Red for Women Strategically Focused Research Network grant 16SFRN27870000. The Atherosclerosis Risk in Communities study has been funded in whole or in part with Federal funds from the National Heart, Lung, and Blood Institute, National Institutes of Health, Department of Health and Human Services, under Contract nos. (HHSN268201700001I, HHSN268201700002I, HHSN268201700003I, HHSN268201700005I, HHSN268201700004I).
Dr. Zhao is also funded by the Blumenthal Scholars Preventive Cardiology Fund and Dr. Michos is funded by the Amato Fund for Women’s Cardiovascular Health Research, both at Johns Hopkins University.
© Endocrine Society 2020. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com